GLI_GLEEVEC_ONCOLOGY
Drug
Novartis Pharma AG
Total Payments
$100,000
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $50,000 | 1 | 0 |
| 2019 | $50,000 | 1 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $100,000 | 2 | 100.0% |
Top Doctors Receiving Payments for GLI_GLEEVEC_ONCOLOGY
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Portland, OR | $100,000 | 2 |
Ad
Manufacturing Companies
- Novartis Pharma AG $100,000
Product Information
- Type Drug
- Total Payments $100,000
- Total Doctors 0
- Transactions 2
About GLI_GLEEVEC_ONCOLOGY
GLI_GLEEVEC_ONCOLOGY is a drug associated with $100,000 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2019 to 2020. In 2020, $50,000 was paid across 1 transactions to 0 doctors.
The most common payment nature for GLI_GLEEVEC_ONCOLOGY is "Royalty or License" ($100,000, 100.0% of total).